Resverlogix (RVX) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free RVX Stock Alerts C$0.06 -0.01 (-14.29%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 6:09 PM | finance.yahoo.comResverlogix Corp. (RVX.TO)May 16 at 6:00 AM | americanbankingnews.comResverlogix (TSE:RVX) Share Price Passes Above Fifty Day Moving Average of $0.06May 13, 2024 | finance.yahoo.comResverlogix Announces Two-Year Extension of Debenture and Elimination of Conversion PrivilegesFebruary 21, 2024 | finance.yahoo.comResverlogix Announces Change to Its Board of DirectorsJanuary 11, 2024 | finance.yahoo.comResverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic BenefitsJanuary 4, 2024 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Tuesday (RVX)December 19, 2023 | investing.comResverlogix Corp. (RVX) Earnings Dates & ReportsNovember 18, 2023 | morningstar.comResverlogix Corp RVXCFNovember 1, 2023 | morningstar.comResverlogix Corp RVXOctober 18, 2023 | theglobeandmail.comResverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)October 4, 2023 | finanznachrichten.deResverlogix Corp.: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophyOctober 4, 2023 | finance.yahoo.comResverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophySeptember 26, 2023 | finance.yahoo.comAtherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsightAugust 29, 2023 | finance.yahoo.comResverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 DiabetesAugust 24, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp up on Wednesday (RVX)August 14, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Monday (RVX)July 12, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)June 29, 2023 | finance.yahoo.comResverlogix Announces Warrant Repricing and One-Year ExtensionJune 20, 2023 | finanznachrichten.deResverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of ShareholdersJune 20, 2023 | finance.yahoo.comResverlogix Announces Voting Results from the 2023 Meeting of ShareholdersJune 12, 2023 | finance.yahoo.comResverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease PatientsJune 7, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - RVX.WT.AJune 6, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)May 25, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)May 18, 2023 | finance.yahoo.comCBOE RUSSELL 2000 VOLATILITY IN (^RVX)May 2, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Monday (RVX)April 29, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Friday (RVX)April 28, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Thursday (RVX-WT-A)April 27, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp up on Thursday (RVX)April 27, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Wednesday (RVX)April 25, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Tuesday (RVX)April 22, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Friday (RVX)April 18, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Friday (RVX-WT-A)April 15, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp up on Friday (RVX)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Tuesday (RVX-WT-A)April 12, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Monday (RVX-WT-A)April 8, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Thursday (RVX)March 20, 2023 | msn.comResverlogix extends debenture maturity by one yearMarch 2, 2023 | finance.yahoo.comResverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19December 11, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$43k as Resverlogix Corp. (TSE:RVX) drops to CA$44mSeptember 30, 2022 | globenewswire.comInvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone's Future Development for the Prevention and Treatment of Post COVID-19 Conditions - GlobeNewswireSeptember 30, 2022 | finance.yahoo.comInvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 ConditionsSeptember 28, 2022 | globenewswire.comResverlogix Confirms Focus on Treatment of Post COVID-19 Conditions - GlobeNewswireSeptember 28, 2022 | finance.yahoo.comResverlogix Confirms Focus on Treatment of Post COVID-19 ConditionsSeptember 15, 2022 | reuters.comRVX.TO - Resverlogix Corp. | Stock Price & Latest News | ReutersAugust 22, 2022 | globenewswire.comResverlogix Publishes New Data Highlighting Apabetalone's - GlobeNewswireAugust 22, 2022 | finance.yahoo.comResverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver DiseaseAugust 16, 2022 | globenewswire.comResverlogix Announces Appointment of New Chief Scientific Officer - GlobeNewswire Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film. Take a look. RVX Media Mentions By Week RVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVX News Sentiment▼0.820.50▲Average Medical News Sentiment RVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVX Articles This Week▼30▲RVX Articles Average Week Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Antibe Therapeutics News Today Kane Biotech News Today Sirona Biochem News Today Ceapro News Today Covalon Technologies News Today Aptose Biosciences News Today Innovotech News Today Quest PharmaTech News Today IBEX Technologies News Today Microbix Biosystems News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:RVX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
